MCL1 and non-small cell lung carcinoma: Conversely, not all instances of resistance were attributed to Mcl1 expression, as reported for cisplatin-treated non-small cell lung cancer cells (NSCLC), which induced cell death independently of Mcl1 expression levels [151].